On July 16, 2013, Fortune China published its 2013 Top 500 list for Chinese companies. Huadong Medicine Co., Ltd. (hereinafter referred to as “Huadong Medicine”) ranked 288th this year with RMB 14.579 billion of operating revenue, climbing 36 rungs from last year.

Among the top 500 companies, only 17 enterprises from the industries of pharmacy, bio-products and healthcare won their places on the list, including two from Zhejiang province, Huadong Medicine  and  Zhejiang Int'l Group Co.,ltd(ranking 369th). A total of 24 Zhejiang enterprises have made their way onto the list.

Huadong Medicine is now faced with both opportunities and challenges. The new GMP certification program has accelerated the reshuffle in the pharmaceutical industry. Huadong Medicine will speed up the transformation and upgrade in production, marketing, scientific research and management.